Cilastatin sodium is a synthetic inhibitor of the renal enzyme dehydropeptidase I, used clinically in combination with the antibiotic imipenem to prevent its renal degradation and enhance therapeutic efficacy.… Read more











Cilastatin sodium is a synthetic inhibitor of the renal enzyme dehydropeptidase I, used clinically in combination with the antibiotic imipenem to prevent its renal degradation and enhance therapeutic efficacy. This category contains reference standards for the cilastatin sodium active pharmaceutical ingredient (API), alongside a comprehensive selection of its related compounds. Pharmaceutical laboratories utilize these pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds for rigorous analytical testing, method validation, and routine quality control procedures. By providing high-quality material for impurity profiling and assay verification, these standards support the ongoing monitoring of synthetic processes and the stability of pharmaceutical formulations. Each compound serves as a critical component in ensuring the accuracy of quantitative analyses and the adherence of drug products to established regulatory specifications.